vibrocil duo 0,5 mg/ml+0,6mg/ml
glaxosmithkline consumer healthcare gmbh & co. kg - germania - xylometazolinum+ipratropiu - spray naz.,sol. - 0,5mg/ml+0,6mg/ml - decongestionante si alte medicamente nazale de uz topic simpatomimetice, combinatii excl.corticosteroizi
polymic comprimate filmate 200 mg + 500 mg
kusum healthcare pvt.ltd - metoclopramidum + ornidazolum - comprimate filmate - 200 mg + 500 mg
neostigmina lph 15 mg
labormed pharma s.a. - romania - neostigmini bromidum - compr. - 15mg - parasimpatomimetice anticolinesterazice
mestinon 60 mg
labiana pharmaceuticals s.l. - spania - pyridostigmini bromidum - draj. - 60mg - parasimpatomimetice anticolinesterazice
bysimin 20 mg/ml
medochemie ltd. - cipru - butylscopolammonii bromidum - sol. inj. - 20mg/ml - belladonna si derivati alcaloizi din belladonna compusi cuaternari de amoniu semis.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
mestinon 60 mg
labiana pharmaceuticals s.l. - spania - pyridostigmini bromidum - draj. - 60mg - parasimpatomimetice anticolinesterazice
algifen 500 mg/5 mg/0,1 mg
zentiva s.a. - romania - combinatii (metamizolum natrium+pitofenoni hydrochloridum+fenpiverini bromidum) - compr. - 500mg/5mg/0,1mg - antispastice in asociere cu analgezice anticolinergice de sinteza in combinatii cu analgezice